{"transactions":[{"id":3681505,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61125,"kind":"person","name":"Wong Ryan Ho-Yan","position":1,"cik":"0002079673","reported_name":"Wong Ryan Ho-Yan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-09T00:05:04.000Z","date":"2026-09-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":13272,"price":22.22,"value":294903.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on September 3, 2025."}],"balance_after":121792,"source":{"system":"sec-edgar","filing":"0001193125-26-385545","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2079673/000119312526385545/ownership.xml","form_type":"4"}},{"id":3680425,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61124,"kind":"person","name":"Estepan Ian Michael","position":1,"cik":"0001836254","reported_name":"Estepan Ian Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-09T00:03:04.000Z","date":"2026-09-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":24799,"price":22.22,"value":551033.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on September 3, 2025."}],"balance_after":177184,"source":{"system":"sec-edgar","filing":"0001193125-26-385544","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836254/000119312526385544/ownership.xml","form_type":"4"}},{"id":3679675,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2026-09-09T00:02:03.000Z","date":"2026-09-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":22025,"price":22.22,"value":489395.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on September 3, 2025."}],"balance_after":115519,"source":{"system":"sec-edgar","filing":"0001193125-26-385541","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2046214/000119312526385541/ownership.xml","form_type":"4"}},{"id":3679050,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Common Stock","published_at":"2026-09-09T00:01:03.000Z","date":"2026-09-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":21423,"price":22.22,"value":476019.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on September 3, 2025."}],"balance_after":203900,"source":{"system":"sec-edgar","filing":"0001193125-26-385536","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836218/000119312526385536/ownership.xml","form_type":"4"}},{"id":701798,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (right to buy)","published_at":"2026-07-30T00:05:03.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":2224342,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents the date upon which the first twenty-five percent of the option granted vests. 1/48th of the total granted option vests and becomes exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continued employment."}],"balance_after":2224342,"derivative":{"exercise_price":17.74,"exercise_date":"2027-07-28","expiration_date":"2036-07-28","underlying":"Common Stock","underlying_shares":2224342},"source":{"system":"sec-edgar","filing":"0001193125-26-324445","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526324445/ownership.xml","form_type":"4"}},{"id":701797,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":11604,"kind":"person","name":"SEVERINO MICHAEL","position":1,"cik":"0001609447","reported_name":"SEVERINO MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-30T00:05:03.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":756104,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in substantially equal installments on an annual basis over four years from the date of grant, subject to the Reporting Person's continued employment."}],"balance_after":756104,"source":{"system":"sec-edgar","filing":"0001193125-26-324445","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526324445/ownership.xml","form_type":"4"}},{"id":748752,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41123,"kind":"person","name":"Boor Kathryn Jean","position":1,"cik":"0001761826","reported_name":"Boor Kathryn Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-06T00:11:02.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":16875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest on earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting."}],"balance_after":25138,"source":{"system":"sec-edgar","filing":"0001193125-26-260263","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526260263/ownership.xml","form_type":"4"}},{"id":748753,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-06T00:10:04.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":16875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest on earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting."}],"balance_after":18640,"source":{"system":"sec-edgar","filing":"0001193125-26-260261","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526260261/ownership.xml","form_type":"4"}},{"id":748751,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-06T00:09:02.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":16875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest on earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting."}],"balance_after":42098,"source":{"system":"sec-edgar","filing":"0001193125-26-260259","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526260259/ownership.xml","form_type":"4"}},{"id":748750,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-06T00:08:04.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":16875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest on earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting."}],"balance_after":214357,"source":{"system":"sec-edgar","filing":"0001193125-26-260257","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526260257/ownership.xml","form_type":"4"}},{"id":748749,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":13339,"kind":"person","name":"Connelly Deirdre P","position":1,"cik":"0001303417","reported_name":"Connelly Deirdre P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-06T00:07:02.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":16875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest on earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting."}],"balance_after":22100,"source":{"system":"sec-edgar","filing":"0001193125-26-260255","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526260255/ownership.xml","form_type":"4"}},{"id":748748,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-06T00:04:03.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":16875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest on earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting."}],"balance_after":48407,"source":{"system":"sec-edgar","filing":"0001193125-26-260250","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526260250/ownership.xml","form_type":"4"}},{"id":748747,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41120,"kind":"person","name":"Chambers Michael Andrew","position":1,"cik":"0001932527","reported_name":"Chambers Michael Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-06T00:02:04.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":16875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest on earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting."}],"balance_after":27535,"source":{"system":"sec-edgar","filing":"0001193125-26-260246","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526260246/ownership.xml","form_type":"4"}},{"id":748746,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-06T00:02:03.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":16875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest on earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting."}],"balance_after":2983542,"source":{"system":"sec-edgar","filing":"0001193125-26-260245","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526260245/ownership.xml","form_type":"4"}},{"id":844803,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61124,"kind":"person","name":"Estepan Ian Michael","position":1,"cik":"0001836254","reported_name":"Estepan Ian Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-14T00:09:03.000Z","date":"2026-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1097,"price":17.03,"value":18681.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 10, 2025."}],"balance_after":201983,"source":{"system":"sec-edgar","filing":"0001193125-26-106710","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526106710/ownership.xml","form_type":"4"}},{"id":844804,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61125,"kind":"person","name":"Wong Ryan Ho-Yan","position":1,"cik":"0002079673","reported_name":"Wong Ryan Ho-Yan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-14T00:07:03.000Z","date":"2026-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":256,"price":17.03,"value":4359.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 10, 2025."}],"balance_after":135064,"source":{"system":"sec-edgar","filing":"0001193125-26-106706","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526106706/ownership.xml","form_type":"4"}},{"id":844802,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Common Stock","published_at":"2026-03-14T00:05:03.000Z","date":"2026-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":948,"price":17.03,"value":16144.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 10, 2025."}],"balance_after":225323,"source":{"system":"sec-edgar","filing":"0001193125-26-106703","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526106703/ownership.xml","form_type":"4"}},{"id":844801,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-14T00:03:03.000Z","date":"2026-03-12","kind":"sale","planned":false,"acquired":false,"shares":7239,"price":17.02,"value":123207.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a sale of shares of common stock to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards."}],"balance_after":1765,"source":{"system":"sec-edgar","filing":"0001193125-26-106701","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526106701/ownership.xml","form_type":"4"}},{"id":844800,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2026-03-14T00:01:03.000Z","date":"2026-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":974,"price":17.03,"value":16587.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 10, 2025."}],"balance_after":137544,"source":{"system":"sec-edgar","filing":"0001193125-26-106697","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526106697/ownership.xml","form_type":"4"}},{"id":849652,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61125,"kind":"person","name":"Wong Ryan Ho-Yan","position":1,"cik":"0002079673","reported_name":"Wong Ryan Ho-Yan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-12T00:08:03.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":113,"price":16.95,"value":1915.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023."}],"balance_after":135320,"source":{"system":"sec-edgar","filing":"0001193125-26-102710","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526102710/ownership.xml","form_type":"4"}},{"id":849651,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61125,"kind":"person","name":"Wong Ryan Ho-Yan","position":1,"cik":"0002079673","reported_name":"Wong Ryan Ho-Yan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-12T00:08:03.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":162,"price":16.95,"value":2745.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022."}],"balance_after":135433,"source":{"system":"sec-edgar","filing":"0001193125-26-102710","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526102710/ownership.xml","form_type":"4"}},{"id":849650,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2026-03-12T00:07:03.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":346,"price":16.95,"value":5864.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023."}],"balance_after":138518,"source":{"system":"sec-edgar","filing":"0001193125-26-102708","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526102708/ownership.xml","form_type":"4"}},{"id":849649,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2026-03-12T00:07:03.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":484,"price":16.95,"value":8203.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022."}],"balance_after":138864,"source":{"system":"sec-edgar","filing":"0001193125-26-102708","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526102708/ownership.xml","form_type":"4"}},{"id":849648,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Common Stock","published_at":"2026-03-12T00:04:04.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":895,"price":16.95,"value":15170.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022."}],"balance_after":226271,"source":{"system":"sec-edgar","filing":"0001193125-26-102703","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526102703/ownership.xml","form_type":"4"}},{"id":849647,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Common Stock","published_at":"2026-03-12T00:04:04.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":504,"price":16.95,"value":8542.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023."}],"balance_after":227166,"source":{"system":"sec-edgar","filing":"0001193125-26-102703","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526102703/ownership.xml","form_type":"4"}},{"id":849644,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61124,"kind":"person","name":"Estepan Ian Michael","position":1,"cik":"0001836254","reported_name":"Estepan Ian Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-12T00:01:03.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":583,"price":16.95,"value":9881.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023."}],"balance_after":203080,"source":{"system":"sec-edgar","filing":"0001193125-26-102701","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526102701/ownership.xml","form_type":"4"}},{"id":849643,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61124,"kind":"person","name":"Estepan Ian Michael","position":1,"cik":"0001836254","reported_name":"Estepan Ian Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-12T00:01:03.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":1036,"price":16.95,"value":17560.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022."}],"balance_after":203663,"source":{"system":"sec-edgar","filing":"0001193125-26-102701","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526102701/ownership.xml","form_type":"4"}},{"id":871304,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2026-03-04T01:07:02.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":408,"price":16.2,"value":6609.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024."}],"balance_after":139348,"source":{"system":"sec-edgar","filing":"0001193125-26-089439","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526089439/ownership.xml","form_type":"4"}},{"id":871306,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61125,"kind":"person","name":"Wong Ryan Ho-Yan","position":1,"cik":"0002079673","reported_name":"Wong Ryan Ho-Yan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-04T01:05:02.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":450,"price":16.2,"value":7290.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024."}],"balance_after":135595,"source":{"system":"sec-edgar","filing":"0001193125-26-089433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526089433/ownership.xml","form_type":"4"}},{"id":871303,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61124,"kind":"person","name":"Estepan Ian Michael","position":1,"cik":"0001836254","reported_name":"Estepan Ian Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Performance Stock Units","published_at":"2026-03-04T01:04:02.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":false,"shares":8125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares previously earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The shares vested on March 1, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares previously earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The shares vested on March 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares previously earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The shares vested on March 1, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8125},"source":{"system":"sec-edgar","filing":"0001193125-26-089432","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526089432/ownership.xml","form_type":"4"}},{"id":871302,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61124,"kind":"person","name":"Estepan Ian Michael","position":1,"cik":"0001836254","reported_name":"Estepan Ian Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-04T01:04:02.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":875,"price":16.2,"value":14175.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024."}],"balance_after":204699,"source":{"system":"sec-edgar","filing":"0001193125-26-089432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526089432/ownership.xml","form_type":"4"}},{"id":871301,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61124,"kind":"person","name":"Estepan Ian Michael","position":1,"cik":"0001836254","reported_name":"Estepan Ian Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-04T01:04:02.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":3301,"price":16.2,"value":53476.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of a PSU award granted on March 1, 2024."}],"balance_after":205574,"source":{"system":"sec-edgar","filing":"0001193125-26-089432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526089432/ownership.xml","form_type":"4"}},{"id":871300,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61124,"kind":"person","name":"Estepan Ian Michael","position":1,"cik":"0001836254","reported_name":"Estepan Ian Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-04T01:04:02.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":true,"shares":8125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares previously earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The shares vested on March 1, 2026."}],"balance_after":208875,"source":{"system":"sec-edgar","filing":"0001193125-26-089432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526089432/ownership.xml","form_type":"4"}},{"id":871299,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Performance Stock Units","published_at":"2026-03-04T01:02:02.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":false,"shares":8125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares previously earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The shares vested on March 1, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares previously earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The shares vested on March 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares previously earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The shares vested on March 1, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8125},"source":{"system":"sec-edgar","filing":"0001193125-26-089425","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526089425/ownership.xml","form_type":"4"}},{"id":871298,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Common Stock","published_at":"2026-03-04T01:02:02.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":767,"price":16.2,"value":12425.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024."}],"balance_after":227670,"source":{"system":"sec-edgar","filing":"0001193125-26-089425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526089425/ownership.xml","form_type":"4"}},{"id":871297,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Common Stock","published_at":"2026-03-04T01:02:02.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":3718,"price":16.2,"value":60231.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of a PSU award granted on March 1, 2024."}],"balance_after":228437,"source":{"system":"sec-edgar","filing":"0001193125-26-089425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526089425/ownership.xml","form_type":"4"}},{"id":871296,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Common Stock","published_at":"2026-03-04T01:02:02.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":true,"shares":8125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares previously earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The shares vested on March 1, 2026."}],"balance_after":232155,"source":{"system":"sec-edgar","filing":"0001193125-26-089425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526089425/ownership.xml","form_type":"4"}},{"id":875549,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61124,"kind":"person","name":"Estepan Ian Michael","position":1,"cik":"0001836254","reported_name":"Estepan Ian Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-02T13:00:04.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":false,"shares":5381,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":5381},"source":{"system":"sec-edgar","filing":"0001193125-26-084265","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526084265/ownership.xml","form_type":"4"}},{"id":875548,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61124,"kind":"person","name":"Estepan Ian Michael","position":1,"cik":"0001836254","reported_name":"Estepan Ian Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-02T13:00:04.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":false,"shares":2069,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":2069},"source":{"system":"sec-edgar","filing":"0001193125-26-084265","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526084265/ownership.xml","form_type":"4"}},{"id":875547,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61124,"kind":"person","name":"Estepan Ian Michael","position":1,"cik":"0001836254","reported_name":"Estepan Ian Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-02T13:00:04.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":true,"shares":5381,"price":13.71,"value":73773.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares held by the Reporting Person after the exercise of a stock option."}],"balance_after":200750,"source":{"system":"sec-edgar","filing":"0001193125-26-084265","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526084265/ownership.xml","form_type":"4"}},{"id":875546,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61124,"kind":"person","name":"Estepan Ian Michael","position":1,"cik":"0001836254","reported_name":"Estepan Ian Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-02T13:00:04.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":true,"shares":2069,"price":13.71,"value":28365.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares held by the Reporting Person after the exercise of a stock option."}],"balance_after":195369,"source":{"system":"sec-edgar","filing":"0001193125-26-084265","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526084265/ownership.xml","form_type":"4"}},{"id":878486,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61124,"kind":"person","name":"Estepan Ian Michael","position":1,"cik":"0001836254","reported_name":"Estepan Ian Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Performance Stock Units","published_at":"2026-02-28T01:05:03.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":1875,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."}],"balance_after":8125,"derivative":{"underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001193125-26-083674","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526083674/ownership.xml","form_type":"4"}},{"id":878484,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Performance Stock Units","published_at":"2026-02-28T01:03:03.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":1875,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the\nprescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the\nprescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the\nprescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the\nprescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."}],"balance_after":8125,"derivative":{"underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001193125-26-083671","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526083671/ownership.xml","form_type":"4"}},{"id":928259,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-30T01:05:03.000Z","date":"2026-01-29","kind":"exercise","planned":false,"acquired":false,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001193125-26-029895","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526029895/ownership.xml","form_type":"4"}},{"id":928258,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-30T01:05:03.000Z","date":"2026-01-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":6780,"price":21.23,"value":143939.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy payment by the Reporting Person of the option exercise price. The Reporting Person holds the exercised shares not wittheld by the Issuer."}],"balance_after":31532,"source":{"system":"sec-edgar","filing":"0001193125-26-029895","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526029895/ownership.xml","form_type":"4"}},{"id":928257,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-30T01:05:03.000Z","date":"2026-01-29","kind":"exercise","planned":false,"acquired":true,"shares":10500,"price":13.71,"value":143955.0,"ownership":{"direct":true},"balance_after":38312,"source":{"system":"sec-edgar","filing":"0001193125-26-029895","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526029895/ownership.xml","form_type":"4"}},{"id":928255,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-30T01:04:03.000Z","date":"2026-01-27","kind":"exercise","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001193125-26-029893","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526029893/ownership.xml","form_type":"4"}},{"id":928254,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-30T01:04:03.000Z","date":"2026-01-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":6494,"price":22.17,"value":143971.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy payment by the Reporting Person of the option exercise price. The Reporting Person holds the exercised shares not withheld by the Issuer."}],"balance_after":197482,"source":{"system":"sec-edgar","filing":"0001193125-26-029893","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526029893/ownership.xml","form_type":"4"}},{"id":928253,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41121,"kind":"person","name":"BEHRENS M KATHLEEN","position":1,"cik":"0001211701","reported_name":"BEHRENS M KATHLEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-30T01:04:03.000Z","date":"2026-01-27","kind":"exercise","planned":false,"acquired":true,"shares":10500,"price":13.71,"value":143955.0,"ownership":{"direct":true},"balance_after":203976,"source":{"system":"sec-edgar","filing":"0001193125-26-029893","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526029893/ownership.xml","form_type":"4"}},{"id":962598,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41120,"kind":"person","name":"Chambers Michael Andrew","position":1,"cik":"0001932527","reported_name":"Chambers Michael Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Senior Notes","published_at":"2025-12-19T21:40:45.000Z","date":"2025-12-18","kind":"grant","planned":false,"acquired":true,"reported_value":20000000,"ownership":{"direct":false,"nature":"By Revocable Trust"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On December 10, 2025, the Reporting Person and the Company entered into an exchange agreement related to the exchange by the Reporting Person of $20,000,000 in aggregate principal amount of the Company's 1.25% Convertible Senior Notes due 2027 (the \"2027 Notes\") for a combination of (i) $20,000,000 in aggregate principal amount of the Company's 4.875% Convertible Senior Notes due 2030 (the \"2030 Notes\") and (ii) $2,170,006.66 in cash in a private exchange with the Company. The exchange closed on December 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 10, 2025, the Reporting Person and the Company entered into an exchange agreement related to the exchange by the Reporting Person of $20,000,000 in aggregate principal amount of the Company's 1.25% Convertible Senior Notes due 2027 (the \"2027 Notes\") for a combination of (i) $20,000,000 in aggregate principal amount of the Company's 4.875% Convertible Senior Notes due 2030 (the \"2030 Notes\") and (ii) $2,170,006.66 in cash in a private exchange with the Company. The exchange closed on December 18, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The 2030 Notes are convertible at the election of the holder at any time prior to the close of business on the business day immediately preceding March 1, 2030, provided that certain convertibility conditions are met. On or after March 1, 2030 until the close of business on the second scheduled trading day immediately preceding the maturity date (August 29, 2030), holders may convert their notes at any time, regardless of the foregoing circumstances. Any conversion of the 2030 Notes may be settled in shares of Common Stock, cash or a combination of cash and shares of Common Stock at the Company's election."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The 2030 Notes are convertible at the election of the holder at any time prior to the close of business on the business day immediately preceding March 1, 2030, provided that certain convertibility conditions are met. On or after March 1, 2030 until the close of business on the second scheduled trading day immediately preceding the maturity date (August 29, 2030), holders may convert their notes at any time, regardless of the foregoing circumstances. Any conversion of the 2030 Notes may be settled in shares of Common Stock, cash or a combination of cash and shares of Common Stock at the Company's election."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The 2030 Notes are convertible at the election of the holder at any time prior to the close of business on the business day immediately preceding March 1, 2030, provided that certain convertibility conditions are met. On or after March 1, 2030 until the close of business on the second scheduled trading day immediately preceding the maturity date (August 29, 2030), holders may convert their notes at any time, regardless of the foregoing circumstances. Any conversion of the 2030 Notes may be settled in shares of Common Stock, cash or a combination of cash and shares of Common Stock at the Company's election."}],"derivative":{"exercise_price":60,"underlying":"Common Stock","underlying_shares":333333},"source":{"system":"sec-edgar","filing":"0001193125-25-326980","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525326980/ownership.xml","form_type":"4"}},{"id":962597,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41120,"kind":"person","name":"Chambers Michael Andrew","position":1,"cik":"0001932527","reported_name":"Chambers Michael Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Senior Notes","published_at":"2025-12-19T21:40:45.000Z","date":"2025-12-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"reported_value":20000000,"ownership":{"direct":false,"nature":"By Revocable Trust"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On December 10, 2025, the Reporting Person and the Company entered into an exchange agreement related to the exchange by the Reporting Person of $20,000,000 in aggregate principal amount of the Company's 1.25% Convertible Senior Notes due 2027 (the \"2027 Notes\") for a combination of (i) $20,000,000 in aggregate principal amount of the Company's 4.875% Convertible Senior Notes due 2030 (the \"2030 Notes\") and (ii) $2,170,006.66 in cash in a private exchange with the Company. The exchange closed on December 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 10, 2025, the Reporting Person and the Company entered into an exchange agreement related to the exchange by the Reporting Person of $20,000,000 in aggregate principal amount of the Company's 1.25% Convertible Senior Notes due 2027 (the \"2027 Notes\") for a combination of (i) $20,000,000 in aggregate principal amount of the Company's 4.875% Convertible Senior Notes due 2030 (the \"2030 Notes\") and (ii) $2,170,006.66 in cash in a private exchange with the Company. The exchange closed on December 18, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The 2027 Notes are convertible at the election of the holder at any time prior to the close of business on the business day immediately preceding March 15, 2027, provided that certain convertibility conditions are met. On or after March 15, 2027 until the close of business on the second scheduled trading day immediately preceding the maturity date (September 15, 2027), holders may convert their notes at any time, regardless of the foregoing circumstances. Any conversion of the 2027 Notes may be settled in shares of Common Stock, cash or a combination of cash and shares of Common Stock at the Company's election."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The 2027 Notes are convertible at the election of the holder at any time prior to the close of business on the business day immediately preceding March 15, 2027, provided that certain convertibility conditions are met. On or after March 15, 2027 until the close of business on the second scheduled trading day immediately preceding the maturity date (September 15, 2027), holders may convert their notes at any time, regardless of the foregoing circumstances. Any conversion of the 2027 Notes may be settled in shares of Common Stock, cash or a combination of cash and shares of Common Stock at the Company's election."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The 2027 Notes are convertible at the election of the holder at any time prior to the close of business on the business day immediately preceding March 15, 2027, provided that certain convertibility conditions are met. On or after March 15, 2027 until the close of business on the second scheduled trading day immediately preceding the maturity date (September 15, 2027), holders may convert their notes at any time, regardless of the foregoing circumstances. Any conversion of the 2027 Notes may be settled in shares of Common Stock, cash or a combination of cash and shares of Common Stock at the Company's election."}],"derivative":{"exercise_price":141.97,"underlying":"Common Stock","underlying_shares":140875},"source":{"system":"sec-edgar","filing":"0001193125-25-326980","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525326980/ownership.xml","form_type":"4"}},{"id":963717,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61124,"kind":"person","name":"Estepan Ian Michael","position":1,"cik":"0001836254","reported_name":"Estepan Ian Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-12-19T01:05:03.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":13187,"price":22.31,"value":294201.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a sale of shares of common stock to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.35 to 22.29, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":193300,"source":{"system":"sec-edgar","filing":"0001193125-25-325383","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525325383/ownership.xml","form_type":"4"}},{"id":975184,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61125,"kind":"person","name":"Wong Ryan Ho-Yan","position":1,"cik":"0002079673","reported_name":"Wong Ryan Ho-Yan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-11T01:05:03.000Z","date":"2025-12-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":78,"price":20.96,"value":1634.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 30, 2022."}],"balance_after":136045,"source":{"system":"sec-edgar","filing":"0001193125-25-314652","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525314652/ownership.xml","form_type":"4"}},{"id":975183,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61125,"kind":"person","name":"Wong Ryan Ho-Yan","position":1,"cik":"0002079673","reported_name":"Wong Ryan Ho-Yan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-11T01:05:03.000Z","date":"2025-12-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":80,"price":20.96,"value":1676.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 30, 2021."}],"balance_after":136123,"source":{"system":"sec-edgar","filing":"0001193125-25-314652","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525314652/ownership.xml","form_type":"4"}},{"id":976898,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-10T01:30:03.000Z","date":"2025-12-07","kind":"grant","planned":false,"acquired":true,"shares":269542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs are subject to service- and performance-based vesting criteria."}],"balance_after":929391,"source":{"system":"sec-edgar","filing":"0001193125-25-313184","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525313184/ownership.xml","form_type":"4"}},{"id":976897,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-10T01:30:03.000Z","date":"2025-12-07","kind":"grant","planned":false,"acquired":true,"shares":96541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The Reporting Person was granted Performance Shares, as described in the Company's 2018 Equity Incentive Plan. The Performance Shares are subject to service- and performance-based vesting criteria."}],"balance_after":659849,"source":{"system":"sec-edgar","filing":"0001193125-25-313184","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525313184/ownership.xml","form_type":"4"}},{"id":976896,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-10T01:30:03.000Z","date":"2025-12-07","kind":"grant","planned":false,"acquired":true,"shares":73001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The Reporting Person was granted Performance Units, as described in the Company's 2018 Equity Incentive Plan. The Performance Units are subject to service- and performance-based vesting criteria."}],"balance_after":563308,"source":{"system":"sec-edgar","filing":"0001193125-25-313184","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525313184/ownership.xml","form_type":"4"}},{"id":976895,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-10T01:30:03.000Z","date":"2025-12-07","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person was granted restricted shares, as described in the Company's 2018 Equity Incentive Plan. The restricted shares are subject to service- and performance-based vesting criteria."}],"balance_after":490307,"source":{"system":"sec-edgar","filing":"0001193125-25-313184","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525313184/ownership.xml","form_type":"4"}},{"id":976894,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39693,"kind":"person","name":"INGRAM DOUGLAS S","position":1,"cik":"0001190644","reported_name":"INGRAM DOUGLAS S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-10T01:30:03.000Z","date":"2025-12-07","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted performance-contingent restricted stock units (\"Performance-Contingent RSUs\"), as described in the Company's 2018 Equity Incentive Plan. Each Performance-Contingent RSU represents the right to receive one share of common stock. The Performance-Contingent RSUs are subject to service- and performance-based vesting criteria."}],"balance_after":440307,"source":{"system":"sec-edgar","filing":"0001193125-25-313184","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525313184/ownership.xml","form_type":"4"}},{"id":984311,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-12-03T01:02:03.000Z","date":"2025-11-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":229,"price":21.12,"value":4836.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 26, 2024."}],"balance_after":139756,"source":{"system":"sec-edgar","filing":"0001193125-25-305662","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525305662/ownership.xml","form_type":"4"}},{"id":994605,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Common Stock","published_at":"2025-11-20T01:05:03.000Z","date":"2025-11-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":4582,"price":18.42,"value":84400.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 16, 2021."}],"balance_after":224030,"source":{"system":"sec-edgar","filing":"0001193125-25-288556","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525288556/ownership.xml","form_type":"4"}},{"id":1047171,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Common Stock","published_at":"2025-09-06T01:30:08.000Z","date":"2025-09-03","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 100% of the RSUs will vest on September 3, 2028, subject to the Reporting Person's continued service to the Company and only if certain performance criteria has been deemed achieved by the Compensation Committee of the Board."}],"balance_after":228612,"source":{"system":"sec-edgar","filing":"0001193125-25-197425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525197425/ownership.xml","form_type":"4"}},{"id":1047170,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Common Stock","published_at":"2025-09-06T01:30:08.000Z","date":"2025-09-03","kind":"grant","planned":false,"acquired":true,"shares":93875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 50% of the RSUs will vest on September 3, 2026, and the remaining 50% will vest on September 3, 2027, subject to the Reporting Person's continued service to the Company."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 106 shares of common stock purchased on August 31, 2025 through the Company's Employee Stock Purchase Plan"}],"balance_after":178612,"source":{"system":"sec-edgar","filing":"0001193125-25-197425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525197425/ownership.xml","form_type":"4"}},{"id":1047167,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61125,"kind":"person","name":"Wong Ryan Ho-Yan","position":1,"cik":"0002079673","reported_name":"Wong Ryan Ho-Yan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-06T01:30:06.000Z","date":"2025-09-03","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 100% of the RSUs will vest on September 3, 2028, subject to the Reporting Person's continued service to the Company and only if certain performance criteria has been deemed achieved by the Compensation Committee of the Board."}],"balance_after":136203,"source":{"system":"sec-edgar","filing":"0001193125-25-197424","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525197424/ownership.xml","form_type":"4"}},{"id":1047166,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61125,"kind":"person","name":"Wong Ryan Ho-Yan","position":1,"cik":"0002079673","reported_name":"Wong Ryan Ho-Yan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-06T01:30:06.000Z","date":"2025-09-03","kind":"grant","planned":false,"acquired":true,"shares":93875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 50% of the RSUs will vest on September 3, 2026, and the remaining 50% will vest on September 3, 2027, subject to the Reporting Person's continued service to the Company."}],"balance_after":111203,"source":{"system":"sec-edgar","filing":"0001193125-25-197424","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525197424/ownership.xml","form_type":"4"}},{"id":1047165,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61124,"kind":"person","name":"Estepan Ian Michael","position":1,"cik":"0001836254","reported_name":"Estepan Ian Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-09-06T01:30:05.000Z","date":"2025-09-03","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 100% of the RSUs will vest on September 3, 2028, subject to the Reporting Person's continued service to the Company and only if certain performance criteria has been deemed achieved by the Compensation Committee of the Board."}],"balance_after":206487,"source":{"system":"sec-edgar","filing":"0001193125-25-197423","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525197423/ownership.xml","form_type":"4"}},{"id":1047164,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61124,"kind":"person","name":"Estepan Ian Michael","position":1,"cik":"0001836254","reported_name":"Estepan Ian Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-09-06T01:30:05.000Z","date":"2025-09-03","kind":"grant","planned":false,"acquired":true,"shares":93875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 50% of the RSUs will vest on September 3, 2026, and the remaining 50% will vest on September 3, 2027, subject to the Reporting Person's continued service to the Company."}],"balance_after":156487,"source":{"system":"sec-edgar","filing":"0001193125-25-197423","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525197423/ownership.xml","form_type":"4"}},{"id":1047163,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-09-06T01:30:03.000Z","date":"2025-09-03","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 100% of the RSUs will vest on September 3, 2028, subject to the Reporting Person's continued service to the Company and only if certain performance criteria has been deemed achieved by the Compensation Committee of the Board."}],"balance_after":139985,"source":{"system":"sec-edgar","filing":"0001193125-25-197422","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525197422/ownership.xml","form_type":"4"}},{"id":1047162,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-09-06T01:30:03.000Z","date":"2025-09-03","kind":"grant","planned":false,"acquired":true,"shares":93875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 50% of the RSUs will vest on September 3, 2026, and the remaining 50% will vest on September 3, 2027, subject to the Reporting Person's continued service to the Company."}],"balance_after":114985,"source":{"system":"sec-edgar","filing":"0001193125-25-197422","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312525197422/ownership.xml","form_type":"4"}},{"id":1073484,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Performance Stock Units","published_at":"2025-08-07T00:03:04.000Z","date":"2025-08-05","kind":"grant","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."}],"balance_after":6250,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0000950170-25-104399","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025104399/ownership.xml","form_type":"4"}},{"id":1073483,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61124,"kind":"person","name":"Estepan Ian Michael","position":1,"cik":"0001836254","reported_name":"Estepan Ian Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Performance Stock Units","published_at":"2025-08-07T00:02:27.000Z","date":"2025-08-05","kind":"grant","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."}],"balance_after":6250,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0000950170-25-104398","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025104398/ownership.xml","form_type":"4"}},{"id":1073482,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61123,"kind":"person","name":"Rodino-Klapac Louise","position":1,"cik":"0001836218","reported_name":"Rodino-Klapac Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D and Tech Ops"}}],"security":"Performance Stock Units","published_at":"2025-08-07T00:01:05.000Z","date":"2025-08-05","kind":"grant","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."}],"balance_after":6250,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0000950170-25-104397","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025104397/ownership.xml","form_type":"4"}},{"id":1076827,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61125,"kind":"person","name":"Wong Ryan Ho-Yan","position":1,"cik":"0002079673","reported_name":"Wong Ryan Ho-Yan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-05T00:10:04.000Z","date":"2025-07-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":327,"price":16.42,"value":5369.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on July 30, 2021."}],"balance_after":17328,"source":{"system":"sec-edgar","filing":"0000950170-25-102279","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025102279/ownership.xml","form_type":"4"}},{"id":1143967,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-19T11:32:14.000Z","date":"2025-05-16","kind":"exercise","planned":false,"acquired":false,"shares":12350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":32.63,"exercise_date":"2018-03-10","expiration_date":"2027-03-10","underlying":"Common Stock","underlying_shares":12350},"source":{"system":"sec-edgar","filing":"0000950170-25-073954","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025073954/ownership.xml","form_type":"4"}},{"id":1143966,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T11:32:14.000Z","date":"2025-05-16","kind":"exercise","planned":false,"acquired":true,"shares":12350,"price":32.63,"value":402980.5,"ownership":{"direct":true},"balance_after":2966667,"source":{"system":"sec-edgar","filing":"0000950170-25-073954","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025073954/ownership.xml","form_type":"4"}},{"id":1148205,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-15T11:00:11.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":false,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0000950170-25-071961","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025071961/ownership.xml","form_type":"4"}},{"id":1148204,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-15T11:00:11.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":false,"shares":9746,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":25.18,"exercise_date":"2016-06-02","expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":9746},"source":{"system":"sec-edgar","filing":"0000950170-25-071961","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025071961/ownership.xml","form_type":"4"}},{"id":1148203,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-15T11:00:11.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":true,"shares":10500,"price":13.71,"value":143955.0,"ownership":{"direct":true},"balance_after":2954317,"source":{"system":"sec-edgar","filing":"0000950170-25-071961","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025071961/ownership.xml","form_type":"4"}},{"id":1148202,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41119,"kind":"person","name":"Barry Richard","position":1,"cik":"0001562371","reported_name":"Barry Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-15T11:00:11.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":true,"shares":9746,"price":25.18,"value":245404.28,"ownership":{"direct":true},"balance_after":2943817,"source":{"system":"sec-edgar","filing":"0000950170-25-071961","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025071961/ownership.xml","form_type":"4"}},{"id":1208484,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-03-14T00:00:04.000Z","date":"2025-03-12","kind":"exercise","planned":false,"acquired":false,"shares":9746,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":25.18,"exercise_date":"2016-06-02","expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":9746},"source":{"system":"sec-edgar","filing":"0000950170-25-039037","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025039037/ownership.xml","form_type":"4"}},{"id":1208483,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-14T00:00:04.000Z","date":"2025-03-12","kind":"sale","planned":false,"acquired":false,"shares":2491,"price":99.64,"value":248203.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to cover the exercise price relating to the exercise of stock options to purchase shares, which are scheduled to expire in 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.64 and $99.87, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":27812,"source":{"system":"sec-edgar","filing":"0000950170-25-039037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025039037/ownership.xml","form_type":"4"}},{"id":1208482,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-14T00:00:04.000Z","date":"2025-03-12","kind":"exercise","planned":false,"acquired":true,"shares":9746,"price":25.18,"value":245404.28,"ownership":{"direct":true},"balance_after":30303,"source":{"system":"sec-edgar","filing":"0000950170-25-039037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025039037/ownership.xml","form_type":"4"}},{"id":1213628,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":13339,"kind":"person","name":"Connelly Deirdre P","position":1,"cik":"0001303417","reported_name":"Connelly Deirdre P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-03-12T00:00:20.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":4792,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4792,"derivative":{"exercise_price":99.69,"exercise_date":"2026-03-10","expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":4792},"source":{"system":"sec-edgar","filing":"0000950170-25-037533","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037533/ownership.xml","form_type":"4"}},{"id":1213627,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":13339,"kind":"person","name":"Connelly Deirdre P","position":1,"cik":"0001303417","reported_name":"Connelly Deirdre P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-12T00:00:20.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":2383,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 10, 2026."}],"balance_after":5225,"source":{"system":"sec-edgar","filing":"0000950170-25-037533","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037533/ownership.xml","form_type":"4"}},{"id":1213623,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41123,"kind":"person","name":"Boor Kathryn Jean","position":1,"cik":"0001761826","reported_name":"Boor Kathryn Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-03-12T00:00:18.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":4792,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4792,"derivative":{"exercise_price":99.69,"exercise_date":"2026-03-10","expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":4792},"source":{"system":"sec-edgar","filing":"0000950170-25-037532","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037532/ownership.xml","form_type":"4"}},{"id":1213622,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41123,"kind":"person","name":"Boor Kathryn Jean","position":1,"cik":"0001761826","reported_name":"Boor Kathryn Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-12T00:00:18.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":2383,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 10, 2026."}],"balance_after":8263,"source":{"system":"sec-edgar","filing":"0000950170-25-037532","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037532/ownership.xml","form_type":"4"}},{"id":1213621,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41120,"kind":"person","name":"Chambers Michael Andrew","position":1,"cik":"0001932527","reported_name":"Chambers Michael Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-03-12T00:00:17.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":4792,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4792,"derivative":{"exercise_price":99.69,"exercise_date":"2026-03-10","expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":4792},"source":{"system":"sec-edgar","filing":"0000950170-25-037531","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037531/ownership.xml","form_type":"4"}},{"id":1213620,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41120,"kind":"person","name":"Chambers Michael Andrew","position":1,"cik":"0001932527","reported_name":"Chambers Michael Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-12T00:00:17.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":2383,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 10, 2026."}],"balance_after":10660,"source":{"system":"sec-edgar","filing":"0000950170-25-037531","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037531/ownership.xml","form_type":"4"}},{"id":1213619,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock Options (right to buy)","published_at":"2025-03-12T00:00:12.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":16644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter."}],"balance_after":16644,"derivative":{"exercise_price":99.69,"exercise_date":"2026-03-10","expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":16644},"source":{"system":"sec-edgar","filing":"0000950170-25-037527","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037527/ownership.xml","form_type":"4"}},{"id":1213618,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-03-12T00:00:12.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":8276,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date."}],"balance_after":21110,"source":{"system":"sec-edgar","filing":"0000950170-25-037527","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037527/ownership.xml","form_type":"4"}},{"id":1213617,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61122,"kind":"person","name":"Rothfuss Cristin","position":1,"cik":"0002046214","reported_name":"Rothfuss Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2025-03-12T00:00:12.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":491,"price":100.13,"value":49163.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022."}],"balance_after":12834,"source":{"system":"sec-edgar","filing":"0000950170-25-037527","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037527/ownership.xml","form_type":"4"}},{"id":1213616,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61124,"kind":"person","name":"Estepan Ian Michael","position":1,"cik":"0001836254","reported_name":"Estepan Ian Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2025-03-12T00:00:12.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":16644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter."}],"balance_after":16644,"derivative":{"exercise_price":99.69,"exercise_date":"2026-03-10","expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":16644},"source":{"system":"sec-edgar","filing":"0000950170-25-037519","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037519/ownership.xml","form_type":"4"}},{"id":1213615,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61124,"kind":"person","name":"Estepan Ian Michael","position":1,"cik":"0001836254","reported_name":"Estepan Ian Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance Stock Units","published_at":"2025-03-12T00:00:12.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 7, 2022. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 7, 2022. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 7, 2022. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000950170-25-037519","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037519/ownership.xml","form_type":"4"}},{"id":1213614,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61124,"kind":"person","name":"Estepan Ian Michael","position":1,"cik":"0001836254","reported_name":"Estepan Ian Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-12T00:00:12.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":8276,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date."}],"balance_after":62612,"source":{"system":"sec-edgar","filing":"0000950170-25-037519","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037519/ownership.xml","form_type":"4"}},{"id":1213613,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61124,"kind":"person","name":"Estepan Ian Michael","position":1,"cik":"0001836254","reported_name":"Estepan Ian Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-12T00:00:12.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2890,"price":100.13,"value":289375.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 7, 2022."}],"balance_after":54336,"source":{"system":"sec-edgar","filing":"0000950170-25-037519","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037519/ownership.xml","form_type":"4"}},{"id":1213612,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61124,"kind":"person","name":"Estepan Ian Michael","position":1,"cik":"0001836254","reported_name":"Estepan Ian Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-12T00:00:12.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1051,"price":100.13,"value":105236.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022."}],"balance_after":57226,"source":{"system":"sec-edgar","filing":"0000950170-25-037519","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037519/ownership.xml","form_type":"4"}},{"id":1213611,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":61124,"kind":"person","name":"Estepan Ian Michael","position":1,"cik":"0001836254","reported_name":"Estepan Ian Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-12T00:00:12.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":true,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 7, 2022. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU."}],"balance_after":58277,"source":{"system":"sec-edgar","filing":"0000950170-25-037519","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037519/ownership.xml","form_type":"4"}},{"id":1213610,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-03-12T00:00:11.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":4792,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4792,"derivative":{"exercise_price":99.69,"exercise_date":"2026-03-10","expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":4792},"source":{"system":"sec-edgar","filing":"0000950170-25-037526","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037526/ownership.xml","form_type":"4"}},{"id":1213609,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-12T00:00:11.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":2383,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 10, 2026."}],"balance_after":25223,"source":{"system":"sec-edgar","filing":"0000950170-25-037526","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037526/ownership.xml","form_type":"4"}},{"id":1213608,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-03-12T00:00:10.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":4792,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4792,"derivative":{"exercise_price":99.69,"exercise_date":"2026-03-10","expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":4792},"source":{"system":"sec-edgar","filing":"0000950170-25-037525","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037525/ownership.xml","form_type":"4"}}],"next_cursor":"2025-03-12T00:00:10.000000Z,1213608"}